USA TOLL FREE NUMBER (24x7) - 1800-231-5109
+91-9811604429, +91-9811604479CONTACT US
0item(s)

You have no items in your shopping cart.

Product was successfully added to your shopping cart.

HEPCVIR L

Be the first to review this product

Quick Overview

HEPATITIS-C SINGLE DAILY DOSE GENERIC TABLETS LAUNCHED IN INDIA - PHARMA GIANT CIPLA LTD HAS RELEASED THE GENERIC TABLETS FOR HEPATITIS-C (HCV) TREATMENT ORAL SINGLE DOSE TABLETS (Hepcvir-L (Ledipasvir-Sofosbuvir)). TABLETS FOR HCV

Availability: In stock

₹0.00

Details

TREATMENT RELEASED BY CIPLA ARE A GENERIC VERSION OF THE DRUG MAKER GILEAD SCIENCES INC - HARVONI TABLETS. Cipla said that Hepcvir-L is the first once-a-day, fixed dose oral combination therapy that has been approved for chronic hepatitis C genotype 1 patients. The drug cost price around Twenty Five Thousand (25000) for a bottle of 28 tablets. Hepatitis C is an infectious disease affecting primarily the liver, caused by the HEPATITIS-C virus (HCV).The infection is often asymptomatic, but chronic infection can lead to scarring of the liver and ultimately to cirrhosis, which is generally known after many years. In some cases, those with cirrhosis will go on to develop liver failure, liver cancer, or life-threatening esophageal and gastric varices.

Product Tags

Other people marked this product with these tags:

Use spaces to separate tags. Use single quotes (') for phrases.

  1. Be the first to review this product

Write Your Own Review

This is custom tab. You can add custom tab as an attribute for entire products, or for each categories. You can add CMS content such as sizing guide or videos to enhance product detail.